Roundview Capital LLC boosted its stake in shares of UnitedHealth Group by 4.8% in the fourth quarter. Revenue climbed 9% to $48.7 billion, which was a bit faster than the growth rate most investors were expecting. The dominant statistics will authorize the investment community to govern the size of UnitedHealth Group Incorporated compared to the sales or total assets figures. It also raised its forecast for adjusted earnings per share to $9.65 to $9.85, from $9.30 to $9.60 previously. The company has a 1 Year high price target of $48.8. UnitedHealth Group updated its FY17 guidance to $9.65-9.85 EPS. UnitedHealth Group Inc (NYSE:UNH) has risen 25.12% since September 9, 2016 and is uptrending. The company has market cap of $2.17 billion. The stock is now trading with a distance of 20-Day Simple Moving Average (SMA20) of -0.16%. Following the sale, the director now owns 75,391 shares of the company's stock, valued at $12,264,607.88. The relative volume (ratio between current volume and 3-month average) is presently sitting at 0.80. The firm's revenue was up 9.4% compared to the same quarter previous year. Stockholders of record on Friday, March 10th were issued a dividend of $0.625 per share. The ex-dividend date was Wednesday, March 8th.
The stock now has its Annual Dividend of $1 and an annual Dividend Yield of 2.42 Percent. UnitedHealth Group's dividend payout ratio is now 33.47%.
"COPYRIGHT VIOLATION WARNING: "[[title]]" was originally posted by [[site]] and is the property of of [[site]]. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of U.S. & worldwide copyright laws. The original version of this report can be viewed at [[permalink]]. 1,087 shares were bought by DUFOUR GREGORY A, worth $30,773 on Tuesday, February 28. The share price is now up 5.33% for the past three months. The last closing price is up 6.44% from the 200-day moving average, compared to the S&P 500 which has increased 0.03% over the same time. Following the transaction, the director now directly owns 1,921,191 shares of the company's stock, valued at $310,618,160.88.
UnitedHealth is right for investors who are looking for a blue-chip healthcare stock that is poised to outperform its peers in the next 12 to 18 months.
Burney Co increased Vanguard Mid (VO) stake by 4,630 shares to 10,105 valued at $1.33M in 2016Q4.
ISIS Death Toll from 'Mother of All Bombs' Hits 90
A general view of Achin district, in Jalalabad, after US forces dropped Thursday the bomb, Afghanistan, Friday, April 14, 2017. The statement said it is the responsibility of Afghans, not the USA , to remove the Islamic State group from the country.
UnitedHealth Group Incorporated (UNH) has 964.38 Million shares outstanding and 949.37 Million shares were floated in market. Intellectus Partners LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at approximately $111,000. Earnings, adjusted for amortization costs, were $2.37 per share.
The number of shares now held by investors is 964.85 Million. Following the sale, the director now owns 35,941 shares of the company's stock, valued at $6,141,957.49. The performance for Year to Date (YTD) is 14.36%.Analysts mean Recommendation on a stock is noted at 3.00. The stock of UnitedHealth Group Inc (NYSE:UNH) earned "Buy" rating by Citigroup on Friday, October 2. Finally, Argus reaffirmed a "buy" rating and set a $170.00 price objective on shares of UnitedHealth Group in a report on Monday, January 23rd.
Unitedhealth Group Inc. has 951,165,000 shares now held by shareholders which now trade around the 167.18 mark which totals Unitedhealth Group Inc.'s market capitalisation to 159.02B United States dollars. Envestnet Asset Mngmt invested 0.1% of its portfolio in UnitedHealth Group Inc (NYSE:UNH). If the $176.95 price target is reached, the company will be worth $8.24B more. Mizuho downgraded the stock to "Neutral" rating in Wednesday, November 9 report.
Zacks offers analysts with an Average Broker Rating (or ABR), basing it on sell-side recommendations.
Analysts give UNH stock a consensus buy rating and an average target of $185, suggesting 11% gains.